Neulasta Archives -

AbbVie’s Humira heads a list of seven medicines that collectively contributed to a $5.1 billion increase in US

Humira tops list of drugs with unwarranted US price hikes

https://pharmaphorum.com/news/humira-tops-list-of-drugs-with-unwarranted-us-price-hikes/

Amgen’s second quarter revenues were down 3% as competition pegged back its off-patent drugs Sensipar and Neulasta, but

Cancer update buoys Amgen despite Q2 sales fall

https://pharmaphorum.com/news/cancer-update-buoys-amgen-despite-q2-sales-fall/

Napp’s Pelmeg, a biosimilar of Amgen’s cancer drug Neulasta (pegfilgrastim), has been launched in the UK following approval

Napp launches Neulasta biosimilar in UK

https://pharmaphorum.com/news/napp-launches-neulasta-biosimilar-in-uk/

Amgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar

Amgen faces first Neulasta biosimilar rival as FDA approves Mylan drug

https://pharmaphorum.com/news/amgen-neulasta-biosimilar-fda-mylan-fulphila/

Neulasta